Vistaril is used as a sedative to treat anxiety and tension. Vistaril is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system.

Market Analysis and Insights: Global and China Hydroxyzine Pamoate Oral Capsules Market
This report focuses on global and China Hydroxyzine Pamoate Oral Capsules market.
In 2020, the global Hydroxyzine Pamoate Oral Capsules market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Hydroxyzine Pamoate Oral Capsules market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Hydroxyzine Pamoate Oral Capsules Scope and Market Size
Hydroxyzine Pamoate Oral Capsules market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hydroxyzine Pamoate Oral Capsules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Hydroxyzine Pamoate Oral Capsules market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
25mg
50mg

Segment by Application
Hospital
Clinics
Recovery Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Pfizer
Teva
Amneal
Avet
Mylan
Sandoz
Heritage Pharmaceuticals
KvK-Tech
Barr Pharmaceuticals